510(k) K032334
K032334 is an FDA 510(k) premarket notification submitted by Roche Diagnostics Corp. for the device "ROCHE ONLINE TDM LIDOCAINE". The FDA issued a decision of Substantially Equivalent on January 12, 2004. The device falls under product code KLR (Enzyme Immunoassay, Lidocaine), a Class II device regulated under 21 CFR 862.3555. Roche Diagnostics Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 12, 2004
- Date Received
- July 29, 2003
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Immunoassay, Lidocaine
- Device Class
- Class II
- Regulation Number
- 862.3555
- Review Panel
- TX
- Submission Type